MAGI’s Clinical Research vConference — Fall 2021 October 18-21 and October 25-28, 2021

[ad_1]

WCG CenterWatch

WCG CenterWatch

MAGI’s Clinical Research vConference — Fall 2021

Oct. 18-21 and Oct. 25-28, 2021 • Join Us Virtually

https://www.magiworld.org/EventInfo?EVT=58

A 99% satisfaction rate is worth noting.

MAGI’s Clinical Research vConference – Fall 2021 is set to deliver another stellar experience along with networking opportunities attendees won’t want to miss. All in a carefully crafted virtual format that makes attending more convenient than ever.

Whether one is new to clinical research or a veteran, there are sessions to meet all needs. A sampling of the 70+ sessions include:

Plenary Sessions

  • Keynote — A Clinical Research Roadmap for the Next Five Years: A Panel Discussion
  • Keynote — Equity and Justice in Action: A Panel Discussion

Contracts Track

  • Details Matter: Dissecting a Clinical Trial Agreement (2 Parts)
  • Into the Abyss: Subject Injury and Indemnification
  • Seven Key Intellectual Property Provisions in CTAs

Budgets & Billing Track

  • Constructive Strategies & Tactics for Effective Budget Negotiation
  • Cyberliability and Finding the Balance on Data Security Practices
  • Budget Development & Negotiation for Investigative Sites

Clinical Operations & Project Management Track

  • Revealing Questions to Ask at Site Qualification Visits
  • Setting Your Study Team Up for Success
  • Clinical Project Management: A Skills-Based Workshop (2 Parts)

Quality and Risk Management Track

  • Risky Business: Assessing, Characterizing & Managing Risk in Clinical Research
  • Look Out! The Future of Remote Site Governance
  • Powerful Quality Management Systems for Sponsors, Sites and CROs

Regulatory Compliance Track

  • Would You Approve This Study? Study Approvals at the Edge
  • Site Inspection Readiness: The Decisive GCP Challenge
  • Recent Developments in Subject Data Privacy & Security…and How to Address Them

Site Management Track

  • The Evolving Site Landscape: A Panel Discussion
  • Run Your Site Like a Business
  • Metrics for Site Management & Business Development

Management & Professional Skills Track

  • Streamlining & Simplifying Clinical Trial Processes
  • Conflict Resolution: Address Difficult Situations Before They Get Out of Hand
  • Transform Your Role from Manager to Leader

Patients & Study Participants Track

  • Patient Recruitment & Engagement Innovations & Best Practices
  • What We Can Learn from Experienced Study Participants: A Panel Discussion
  • Roll Out the Red Carpet: How to Treat Study Participants Like Valued Customers

Special Topics Track

  • Modern Site Selection: A Panel Discussion
  • Are You Hearing Us? Are We Hearing You? A Panel Discussion
  • Medical Device Clinical Research: Regulatory Challenges (2 Parts)

Convenience is key: MAGI’s Clinical Research vConference sessions will be live AND recorded. Access recordings during the event and for the following two weeks, whenever it works.

Register by July 31 and save $200.

Virtual Conference Details:

MAGI’s Clinical Research vConference — Fall 2021

Oct. 18-21 and Oct. 25-28, 2021 • Join Us Virtually

https://www.magiworld.org/EventInfo?EVT=58

Tuition:

All Access Pass – $995

Easy Ways to Register:

Online: https://www.magiworld.org/EventInfo?EVT=58

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

[ad_2]

Leave a Reply